KLRS
Kalaris Therapeutics
KLRS
KLRS
75 hedge funds and large institutions have $600M invested in Kalaris Therapeutics in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 10 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.22% more ownership
Funds ownership: 1.56% → 1.78% (+0.22%)
30% less capital invested
Capital invested by funds: $854M → $600M (-$254M)
Holders
75
Holding in Top 10
–
Calls
$5.24M
Puts
$44K
Top Buyers
| 1 | +$18.9M | |
| 2 | +$18.2M | |
| 3 | +$13.1M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$11.5M |
| 5 |
Goldman Sachs
New York
|
+$5.85M |
Top Sellers
| 1 | -$8.94M | |
| 2 | -$5.12M | |
| 3 | -$4.1M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$2.61M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$1.92M |